Theodore Scott Nowicki

8PUBLICATIONS
89CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 02, 2025
Human cancer-targeted immunity via transgenic hematopoietic stem cell progeny.

Theodore S Nowicki, Nataly Naser Al Deen, Cole W Peters

|Sep 13, 2024
Hypophosphatemia Correction Reduces ICANS Incidence and Duration in CAR T-cell Therapy: A Pooled Clinical Trial Analysis.

Jack Pengfei Tang, Penelope Lafeuille, Alexandru Socolov

|Oct 23, 2023
Infusion Product TNFα, Th2, and STAT3 Activities Are Associated with Clinical Responses to Transgenic T-cell Receptor Cell Therapy.

Theodore S Nowicki, Cole W Peters, Crystal Quiros

|Aug 25, 2023
A Pilot Study of Neoadjuvant Nivolumab, Ipilimumab, and Intralesional Oncolytic Virotherapy for HER2-negative Breast Cancer.

Vina P Nguyen, Katie M Campbell, Theodore S Nowicki

Pageof 2